Jianan Li

Title: Innovations of Jianan Li in Base Editing

Introduction

Jianan Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of genetic engineering, particularly in the area of base editing. His innovative work has the potential to revolutionize genetic modifications and therapeutic applications.

Latest Patents

Jianan Li holds a patent for fusion proteins designed for base editing. This patent includes fusion proteins that consist of an apolipoprotein B mRNA editing enzyme catalytic subunit 3A (APOBEC3A) and a clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas) protein. Additionally, the fusion protein may include a uracil glycosylase inhibitor (UGI). This technology enables the deamination of cytosine to uracil in DNA, even in challenging contexts such as GpC or methylated cytosines.

Career Highlights

Jianan Li is affiliated with Shanghaitech University, where he conducts research and develops innovative solutions in genetic engineering. His work has garnered attention for its potential applications in various fields, including medicine and biotechnology.

Collaborations

Jianan Li collaborates with notable colleagues, including Jia Chen and Li Yang. Their combined expertise enhances the research and development efforts in their respective projects.

Conclusion

Jianan Li's contributions to base editing through his innovative patent demonstrate his commitment to advancing genetic engineering. His work at Shanghaitech University and collaborations with esteemed colleagues position him as a key figure in this transformative field.